• Explore /
  • Poster
  • / Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis.

Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis.

Abstract Poster

Authors

A. Sartor

A. Oliver Sartor

Tulane Medical School, New Orleans, LA

A. Oliver Sartor , Andrew J. Armstrong , Chiledum Ahaghotu , David G. McLeod , Matthew R. Cooperberg , David F. Penson , Philip W. Kantoff , Nicholas J. Vogelzang , Arif Hussain , Christopher Michael Pieczonka , Neal D. Shore , David I. Quinn , Eric Jay Small , Elisabeth I. Heath , Ronald F Tutrone , Paul F. Schellhammer , Matthew Harmon , Nancy N. Chang , Stephen J. Freedland , Celestia S. Higano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT01306890

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5035)

DOI

10.1200/JCO.2019.37.15_suppl.5035

Abstract #

5035

Poster Bd #

147

Abstract Disclosures

Similar Posters

First Author: Andrew J. Armstrong

First Author: Kelvin A. Moses

Poster

2014 Genitourinary Cancers Symposium

Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.

Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.

First Author: Charles G. Drake

First Author: David D. Chism